Actively Recruiting
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-04-13
850
Participants Needed
1
Research Sites
1323 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Most symptoms of human papillomaviruses (HPV) infection, do not cause serious health problems, but some do. As HPV can cause uncontrolled growth of infected cells, some people can develop benign skin lesions, larger warts, genital lesions, tumors or cysts that do not respond to treatment. Researchers want to learn why. Objective: To better understand why some people are more likely than others to get sick from HPV infection, and why medicine or surgery is not always effective. Eligibility: People aged 3 years and older who have had multiple outbreaks of HPV-related warts and/or lesions that do not respond to treatment. Healthy relatives are also needed. Design: Participants will be screened with a medical history, physical exam, and blood tests. Participants may have study visits as an outpatient or an inpatient (admitted overnight to the NIH hospital) and be followed over several years by our doctors and researchers at the NIH. Participants may have a cervical and/or anal Pap test. They may give samples of semen, cervicovaginal secretions, urine, saliva, or stool. Small pieces of skin, the inside of the cheek, and/or the gums may be collected with a punch or scrape biopsy to understand how HPV affect the growth of cells. Mucus and skin may be collected by rubbing the area with a cotton swab. Collection areas may include the inside the mouth, nostrils, skin, genitals, and/or in or around the anus. Biopsies may be collected. If participants need to have a biopsy as part of medical care, then we may ask if extra samples can be collected for research. Biopsies we may collect are bone marrow, lymph node, genitals, or in or around the anus. Participants may have leukapheresis. Blood is taken from a needle placed in one arm. A machine separates out the white blood cells. The rest of the blood is returned through a needle in their other arm. Samples may be used for genetic tests and/or to make special cells called induced pluripotent stem cells. Participants may have follow-up visits once a year for 10 years. Benefits: We are not testing new HPV treatments in this study and you might not benefit from participating. However, we may learn new information about your condition that we will share with you and your doctor. We may make recommendations for your medical care based on current accepted treatment. What we learn from you and other participants in this study might help other people. We hope we can use this information to develop new treatments and therapies in the future....
CONDITIONS
Official Title
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 3 years or older (household contacts and sexual partners must be aged 18 or older)
- Able to provide informed consent or have a parent/legal guardian provide consent if under 18
- Willing to allow genetic testing on collected biological samples
- For participants with HPV-related diseases: severe, widespread, recurring, and treatment-resistant HPV infection confirmed by medical records or health history
- Multiple recurrent or treatment-resistant skin warts (5 or more) without known immunodeficiency
- Concurrent skin warts and mucosal HPV-related diseases
- Recurrent or treatment-resistant mucosal condyloma or other HPV diseases
- Mucosal HPV diseases involving more than one mucosal site
- Participants with known immunodeficiency and any skin or mucosal HPV diseases
- Recurrent invasive HPV-related squamous cell carcinoma
- History or current evidence of invasive HPV-related squamous cell carcinoma with family history
- Healthy biological relatives, household contacts, or sexual partners without severe HPV disease or who do not meet criteria for affected participant
You will not qualify if you...
- Laboratory abnormalities contraindicating participation, such as neutropenia (absolute neutrophil count <500 cells/microL) or thrombocytopenia (platelets <10,000/microL) within 90 days before screening
- Inability to reliably keep research appointments or adhere to study procedures
- Any condition deemed by the investigator to contraindicate participation
- Healthy controls with HPV-related disease that would qualify them as affected participants rather than controls
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
A
Andrea Lisco, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here